Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea

American Journal of Transplantation

Volumn 5, Issue 6, 2005, Pages 1383-1391

  Lemahieu, Wim ^a   Maes, Bart ^a   Verbeke, Kristin ^a   Rutgeerts, Paul ^a   Geboes, Karel ^a   Vanrenterghem, Yves ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Diarrhea; Mofetil mycophenolate; P glycoprotein; Tacrolimus; Transplantation

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMLODIPINE; ATENOLOL; ATORVASTATIN; BISOPROLOL; CIMETIDINE; CORTICOSTEROID; CYTOCHROME P450 3A4; DOXYCYCLINE; ENALAPRIL; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; LISINOPRIL; LORATADINE; LORAZEPAM; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIMESULIDE; OMEPRAZOLE; PHENPROCOUMON; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE; TACROLIMUS; TERAZOSIN; VALSARTAN; ZOLPIDEM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BIOLOGICAL AVAILABILITY; CYTOCHROME P-450 ENZYME SYSTEM; DIARRHEA; FECES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; KIDNEY TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 20544453483     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00844.x     Document Type: Article

References (28)

1. Sellin JH. The pathophysiology of diarrhea. Clin Transplant 2001; 15(Suppl. 4): 2-10.
2. Maes BD, Dalle I, Geboes K et al. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation 2003; 75: 665-672.
3. Maes B, Lemahieu W, Kuypers D et al. Differential effect of diarrhea on FK 506 versus Cyclosporin A trough levels and resultant prevention of allograft rejection in renal transplant recipients. Am J Transplant 2002; 2: 989-992.
4. Iglesias BJ, Lopez-Espinosa JA, Ortega-Lopez J et al. Two-to three-fold increase in blood Tacrolimus (FK 506) levels during diarrhea in liver-transplanted children. Clin Transplant 2003; 17: 249-253.
5. Staatz CE, Taylor PJ, Lynch SV, Tett SE. A pharmacodynamic investigation of Tacrolimus in pediatric liver transplantation. Liver Transpl 2004; 10: 506-512.
6. Teisseyre J, Teisseyre M, Kalicinski P et al. Elevated tacrolimus levels during diarrhea in children after liver transplantation. Transplant Proc 2003; 35: 2292-2294.
7. Fruhwirth M, Fischer H, Simma B, Ellemunter H. Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report. Pediatr Transplant 2001; 5: 132-134.
8. Mittal N, Thompson JF, Kato T, Tzakis AG. Tacrolimus and diarrhea: pathogenesis of altered metabolism. Pediatr Transplant 2001; 5: 75-79.
9. Masuda S, Uemoto S, Hashida T, Inomata Y, Tanaka K, Ken-ichi I. Effect of intestinal P-glycoprotein on daily Tacrolimus trough level in a living donor small bowel recipient. Clin Pharmacol Ther 2000; 68: 98-103.
10. Ghoos YF, Maes B, Geypens BJ et al. Measurement of gastric emptying rate of solids by means of a carbon labeled octanoic breath test. Gastroenterology 1993; 104: 1640-1647.
11. Maes B, Geypens BJ, Ghoos YF, Hiele MI, Rutgeerts PJ. 13C-Octanoic acid breath test for gastric emptying rate of solids. Gastroenterology 1998; 114: 856-859.
12. Maes BD, Mys G, Geypens BJ, Evenepoel P, Ghoos Y, Rutgeerts PJ. Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results. Am J Physiol Gastrointest Liver Physiol 1998; 275: 169-175.
13. Lemahieu W, Maes B, Vanrenterghem Y, Rutgeerts P, Verbeke K, Ghoos Y. Measurement of hepatic and intestinal cyp 3A4 and P-glycoprotein activity by means of a combined po and iv C14 Erythromycin breath and urine test. Am J Physiol Gastrointest Liver Physiol 2003; 285: 470-482.
14. Mion F, Queneau PE, Rousseau M, Brazier JL, Paliard, Minaire Y. Aminopyrin breath test: development of a 13C-breath test for quantitative assessment of liver function in humans. Hepatogastroenterology 1995; 42: 931-938.
15. Cogill JL, Taylor PJ, Westley IS, Morris RG, Lynch SV, Johnson AG. Evaluation of the Tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998; 44: 1942-1946.
16. Ghoos Y, Vantrappen G. Clean collection and manipulation of stools. Lancet 1977; 1: 284.
17. Jeejeeboy KN, Ahmad S, Kozak C. Determination of faecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem 1970; 3: 157-163.
18. Fromm H, Hofmann AF. Breath test for altered bile-acid metabolism. Lancet 1971; 2: 621-625.
19. Rutgeerts P, Ghoos Y, Vantrappen G. Bile acid studies in patients with Crohn's colitis. Gut 1979; 20: 1072-1077.
20. Hiele M, Ghoos Y, Rugeerts P, Carchon H, Eggermont E. 13CO2 breath test using naturally 13C-enriched lactose for detection of lactase deficiency in patients with gastrointestinal symptoms. J Lab Clin Med 1988; 112: 193-200.
21. Suenaert P, Bulteel V, Den Hond E et al. In vivo influence of nicotine on human basal and NSAID-induced gut barrier function. Scand J Gastroenterol 2003; 38: 399-408.
22. Watkins PB. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv Drug Deliv Rev 1997; 15: 161-170.
23. Plosker GL, Foster RH. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 2000; 59: 323-389.
24. Blokzijl H, Vander Borght S, Libbrecht L et al. Multidrug Resistance Protein (MDR1) is decreased in inflamed intestinal epithelium in inflammatory bowel disease. Annu Meet Dutch Soc Gastroenterol 2004; 1: 94.
25. Undre NA, Schäfer A and the European Tacrolimus Multicentre Renal Study Group. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. Transplant Proc 1998; 30: 1261-1263.
26. Bekersky I, Dressler D, Mekki QA. Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. J Clin Pharmacol 2001; 41: 176-182.
27. Madsen KL, Yanchar NL, Sigalet DL, Reigel T, Fedorak RN. FK 506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology 1995; 109: 107-114.
28. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.